ArticleMedicina (Kaunas, Lithuania)2023

Tixagevimab and Cilgavimab (Evusheld) Boosts Antibody Levels to SARS-CoV-2 in End-Stage Renal Disease Patients on Chronic Hemodialysis: A Single-Center Study.

Mohammed Kamal Nassar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.